Delivery Order SPE2DB20D3103-SPE2DB23FL7C6

Award Date 11/28/22
Potential Completion Date 11/29/22
Potential Value $1.7K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $2,322.24 for the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 16, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which runs through December...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $15,727.42 for the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen 0.5 ml. The award was made by the Defense Logistics Agency (DLA), a defense agency, on October 15, 2021, with an ultimate completion date of October 18, 2021. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract, valued at $2,467.38, is for the delivery of the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen 0.5 ml. The contract has a completion date of January 3, 2024 and is a firm-fixed-price delivery order. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $13,650.98 delivery order is for the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen with an ultimate completion date of September 27, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $3,672.41 for the procurement of the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen. The award was made by the Defense Logistics Agency (DLA), a component of the Department of Defense, and has an ultimate completion date of July 14, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) is a Delivery Order valued at $3,606.40, placed by the Defense Logistics Agency (DLA) for the supply of Trulicity 1.5 mg/0.5 ml pens. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen (0.5 ml) with a ceiling value of $5,736.72. The contract has a delivery order structure and firm fixed pricing, and no set-aside designation was used. Amerisourcebergen Drug Corp, as a major pharmaceutical distributor, has an Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,915.16 firm fixed-price delivery order is for the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen. The order does not have a set-aside designation, indicating it was competitively awarded. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $4,102.68, is for the delivery of the pharmaceutical product Trulicity 0.75 mg/0.5 ml pen 0.5 ml. This is a firm fixed-price delivery order contract with a completion date of December 7, 2022. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $3,245.76 for the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen 0.5 ml. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB23FL7C6
    Delivery Order

This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The order is for the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen in the amount of $1,741.68. The contract has a firm-fixed price and runs through November 29, 2022.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.

Generated 2/27/25, 10:24 AM